Next Article in Journal
A Non-Derivatized Assay for the Simultaneous Detection of Amino Acids, Acylcarnitines, Succinylacetone, Creatine, and Guanidinoacetic Acid in Dried Blood Spots via Tandem Mass Spectrometry
Next Article in Special Issue
Newborn Screening for X-Linked Adrenoleukodystrophy
Previous Article in Journal
Critical Newborn Screens in Double Heterozygotes of Inborn Errors of Metabolism—A Clinical Report and Recommendations
Previous Article in Special Issue
The Further Adventures of Newborn Screening for Biotinidase Deficiency: Where It Is at and What We Still Need to Know

A Life in Newborn Screening

Division of Genetics and Genomics, Boston Children’s Hospital, Boston, MA 02115, USA
Department of Pediatrics Harvard Medical School, Boston, MA 02115, USA
Academic Editor: Peter C. J. I. Schielen
Int. J. Neonatal Screen. 2016, 2(4), 14;
Received: 22 September 2016 / Revised: 4 November 2016 / Accepted: 10 November 2016 / Published: 24 November 2016
(This article belongs to the Special Issue Newborn Screening-Past, Present and Future)
Newborn screening has revolutionized the diagnosis of many disorders, notably metabolic disorders. Whereas, formerly, a clinical presentation of developmental delay or other features led to the diagnosis, usually too late for optimal treatment, today it is an abnormal finding in newborn screening which leads to the diagnosis and presymptomatic preventative therapy. It is my good fortune to have been involved in newborn screening for virtually all of my 50 years in metabolic disorders—the first 31 years with direct involvement. I have been part of the expansion of newborn screening from the time of the original Guthrie bacterial assays to the addition of tandem mass spectrometry. Newborn screening continues to be a central part of my professional life. This article describes my journey in newborn screening as a metabolic physician and the hallmarks of this journey within the rich history of newborn screening. View Full-Text
Keywords: newborn screening; expanded screening; my life; medical community; phenylketonuria; PKU; maternal newborn screening; expanded screening; my life; medical community; phenylketonuria; PKU; maternal
Show Figures

Figure 1

MDPI and ACS Style

Levy, H.L. A Life in Newborn Screening. Int. J. Neonatal Screen. 2016, 2, 14.

AMA Style

Levy HL. A Life in Newborn Screening. International Journal of Neonatal Screening. 2016; 2(4):14.

Chicago/Turabian Style

Levy, Harvey L. 2016. "A Life in Newborn Screening" International Journal of Neonatal Screening 2, no. 4: 14.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop